Nasal polyps

Russell A. Settipane, Anju T. Peters, Alexander G. Chiu

Research output: Contribution to journalArticle

Abstract

Nasal polyps occur in 1-4% of the population, usually occurring in the setting of an underlying local or systemic disease. The most common associated condition is chronic rhinosinusitis (CRS). A high prevalence of nasal polyps is also seen in allergic fungal rhinosinusitis, aspirin-exacerbated respiratory disease, Churg-Strauss syndrome, and cystic fibrosis. In the setting of CRS, nasal polyps are not likely to be cured by either medical or surgical therapy; however, control is generally attainable. The best medical evidence supports the use of intranasal corticosteroids for maintenance therapy and short courses of oral corticosteroids for exacerbations. The evidence for short- and long-term antibiotics is much less robust. For patients with symptomatic nasal polyposis nonresponsive to medical therapies, functional endoscopic sinus surgery provides an adjunctive therapeutic option.

Original languageEnglish (US)
JournalAmerican Journal of Rhinology and Allergy
Volume27
Issue numberSUPPL.1
DOIs
StatePublished - May 2013

Fingerprint

Nasal Polyps
Adrenal Cortex Hormones
Churg-Strauss Syndrome
Therapeutics
Nose
Cystic Fibrosis
Aspirin
Anti-Bacterial Agents
Population

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Immunology and Allergy

Cite this

Nasal polyps. / Settipane, Russell A.; Peters, Anju T.; Chiu, Alexander G.

In: American Journal of Rhinology and Allergy, Vol. 27, No. SUPPL.1, 05.2013.

Research output: Contribution to journalArticle

Settipane, Russell A. ; Peters, Anju T. ; Chiu, Alexander G. / Nasal polyps. In: American Journal of Rhinology and Allergy. 2013 ; Vol. 27, No. SUPPL.1.
@article{e5e3de4dd2f1480791bc99c7263b7641,
title = "Nasal polyps",
abstract = "Nasal polyps occur in 1-4{\%} of the population, usually occurring in the setting of an underlying local or systemic disease. The most common associated condition is chronic rhinosinusitis (CRS). A high prevalence of nasal polyps is also seen in allergic fungal rhinosinusitis, aspirin-exacerbated respiratory disease, Churg-Strauss syndrome, and cystic fibrosis. In the setting of CRS, nasal polyps are not likely to be cured by either medical or surgical therapy; however, control is generally attainable. The best medical evidence supports the use of intranasal corticosteroids for maintenance therapy and short courses of oral corticosteroids for exacerbations. The evidence for short- and long-term antibiotics is much less robust. For patients with symptomatic nasal polyposis nonresponsive to medical therapies, functional endoscopic sinus surgery provides an adjunctive therapeutic option.",
author = "Settipane, {Russell A.} and Peters, {Anju T.} and Chiu, {Alexander G.}",
year = "2013",
month = "5",
doi = "10.2500/ajra.2013.27.3926",
language = "English (US)",
volume = "27",
journal = "American Journal of Rhinology and Allergy",
issn = "1945-8924",
publisher = "OceanSide Publications Inc.",
number = "SUPPL.1",

}

TY - JOUR

T1 - Nasal polyps

AU - Settipane, Russell A.

AU - Peters, Anju T.

AU - Chiu, Alexander G.

PY - 2013/5

Y1 - 2013/5

N2 - Nasal polyps occur in 1-4% of the population, usually occurring in the setting of an underlying local or systemic disease. The most common associated condition is chronic rhinosinusitis (CRS). A high prevalence of nasal polyps is also seen in allergic fungal rhinosinusitis, aspirin-exacerbated respiratory disease, Churg-Strauss syndrome, and cystic fibrosis. In the setting of CRS, nasal polyps are not likely to be cured by either medical or surgical therapy; however, control is generally attainable. The best medical evidence supports the use of intranasal corticosteroids for maintenance therapy and short courses of oral corticosteroids for exacerbations. The evidence for short- and long-term antibiotics is much less robust. For patients with symptomatic nasal polyposis nonresponsive to medical therapies, functional endoscopic sinus surgery provides an adjunctive therapeutic option.

AB - Nasal polyps occur in 1-4% of the population, usually occurring in the setting of an underlying local or systemic disease. The most common associated condition is chronic rhinosinusitis (CRS). A high prevalence of nasal polyps is also seen in allergic fungal rhinosinusitis, aspirin-exacerbated respiratory disease, Churg-Strauss syndrome, and cystic fibrosis. In the setting of CRS, nasal polyps are not likely to be cured by either medical or surgical therapy; however, control is generally attainable. The best medical evidence supports the use of intranasal corticosteroids for maintenance therapy and short courses of oral corticosteroids for exacerbations. The evidence for short- and long-term antibiotics is much less robust. For patients with symptomatic nasal polyposis nonresponsive to medical therapies, functional endoscopic sinus surgery provides an adjunctive therapeutic option.

UR - http://www.scopus.com/inward/record.url?scp=84878227089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878227089&partnerID=8YFLogxK

U2 - 10.2500/ajra.2013.27.3926

DO - 10.2500/ajra.2013.27.3926

M3 - Article

VL - 27

JO - American Journal of Rhinology and Allergy

JF - American Journal of Rhinology and Allergy

SN - 1945-8924

IS - SUPPL.1

ER -